Alzheimer's Drug Discovery Foundation logo

Alzheimer's Drug Discovery Foundation

North America, New York, United States, New York

Description

Provides funding to leading scientists who are conducting the most promising, innovative Alzheimer’s drug research worldwide.

Investor Profile

Alzheimer's Drug Discovery Foundation has made 47 investments, with 8 in the past 12 months and 70% as lead.

Stage Focus

  • Grant (55%)
  • Series A (17%)
  • Series B (11%)
  • Series Unknown (11%)
  • Undisclosed (2%)
  • Post Ipo Equity (2%)
  • Seed (2%)

Country Focus

  • United States (70%)
  • Spain (11%)
  • Canada (9%)
  • Switzerland (2%)
  • United Kingdom (2%)
  • The Netherlands (2%)
  • Denmark (2%)
  • Sweden (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Health Diagnostics
  • Pharmaceutical
  • Life Science
  • Medical Device
  • Biopharma
  • Neuroscience
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alzheimer's Drug Discovery Foundation frequently co-invest with?

DC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Cleveland Clinic
North America, Ohio, United States, Cleveland
Co-Investments: 2
Dolby Family Ventures
North America, California, United States, San Francisco
Co-Investments: 7
Boston Harbor Angels
North America, Massachusetts, United States, Boston
Co-Investments: 1
TI
Asia, Shanghai, China, Shanghai
Co-Investments: 2
DeepWork Capital
North America, Florida, United States, Orlando
Co-Investments: 1
Life Science Angels
North America, California, United States, Sunnyvale
Co-Investments: 1
Foundation for a Better World
North America, Georgia, United States, Atlanta
Co-Investments: 2
Brain Trust Accelerator Fund
North America, California, United States, Burlingame
Co-Investments: 2
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 2

Which angels does Alzheimer's Drug Discovery Foundation often collaborate with?

Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Alzheimer's Drug Discovery Foundation?

Modulo Bio

San Diego, California, United States

Modulo Bio is a biotech company that offers a platform for reprogramming neurocells to improve immunity.

BiopharmaBiotechnologyMedicalProduct Research
SeedMar 19, 2025
Amount Raised: $4,800,000
Alamar Biosciences

Fremont, California, United States

Alamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time.

BiotechnologyHealth CareMedical
GrantJan 8, 2025
Amount Raised: $10,000,000
University of Gothenburg

Gothenburg, Vastra Gotaland, Sweden

University of Gothenburg is a school in Gothenburg.

GrantNov 14, 2024
Amount Raised: $1,180,000
GLX Analytix

Copenhagen, Hovedstaden, Denmark

At GLX Analytix, we combine a new, proprietary class of blood biomarker with AI to bring personalized medicine to your healthcare.

BiotechnologyHealth CareMedicalPrecision Medicine
Series UnknownOct 29, 2024
C2N Diagnostics

Saint Louis, Missouri, United States

C2N Diagnostics is a specialty company focused on brain health and neurodegenerative diagnostics, advancing early detection solutions.

BiotechnologyHealth CareHealth DiagnosticsMedicalTherapeutics
GrantSep 25, 2024
Amount Raised: $22,025,000
Neuro Therapia

Ohio, Illinois, United States

Neuro Therapia is developing new therapies for diseases with an underlying component of neuroinflammation.

Health CareNeurosciencePharmaceuticalTherapeutics
Series BAug 6, 2024
Amount Raised: $12,300,000
RetiSpec

Toronto, Ontario, Canada

RetiSpec is a medical imaging startup developing an eye scanner for early detection of Alzheimer’s Disease pathology.

Health CareMedical Device
Series AJul 26, 2024
Amount Raised: $9,975,264
Coya Therapeutics

Houston, Texas, United States

Coya Therapeutics is a T Reg platform company addressing neurodegenerative, autoimmune, and metabolic diseases

BiopharmaBiotechnologyLife Science
Post Ipo EquityMay 20, 2024
Amount Raised: $5,000,000
NeuroAge Therapeutics

San Francisco, California, United States

NeuroAge Therapeutics is a longevity biotech firm that develops new medications to regenerate biological brain aging.

Health CareHealth Diagnostics
GrantMar 7, 2024
Amount Raised: $250,000
Superfluid Dx

San Diego, California, United States

Superfluid Dx is a biotechnology company developing novel blood-based early detection.

BiotechnologyHealth CareLife SciencePharmaceutical
Series ADec 20, 2023